Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
Clinical trial NCT00432172 · COMPLETED
Trial details
- NCT number
- NCT00432172
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-24
- Primary completion
- 2010-09-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.